30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Steve Hoerter

Track

Insider profile

Currently holds positions in Ignyta Inc, Constellation Pharmaceuticals Inc and Deciphera Pharmaceuticals Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 84% 68% 82%
Transactions
5 20% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Ignyta Inc Dec. 8, 2016 -
Independent Director Constellation Pharmaceuticals Inc Sept. 4, 2018 -
President, Chief Executive Officer, Director Deciphera Pharmaceuticals Inc March 18, 2019 -
Chief Commercial Officer Agios Pharmaceuticals Inc Feb. 16, 2016 - March 15, 2019
Senior Vice President, Chief Commercial Officer Clovis Oncology Inc Aug. 29, 2011 - Jan. 25, 2016
Steve Hoerter's trades of MBX Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-20 2025-10-17
B Purchase
44,697 -44.7%
212.35
US$1,001,264 		44,697 -44.7% 212.35 US$1,001,264
2023-12-14 2023-12-13
S Sale
77,169 +0.9%
492.35
US$1,572,527 		77,169 +0.9% 492.35 US$1,572,527
2023-10-31 2023-10-30
S Sale
70,225 -25.6%
281.83
US$4,696,375 		70,225 -25.6% 281.83 US$4,696,375
2023-03-23 2023-03-21
PlS Planned sale
7,500 -100.0%
15.57
US$116,782 		7,500 -100.0% 15.57 US$116,782
2023-02-16 2023-02-14
PlS Planned sale
30,045 -80.0%
16.00
US$480,720 		30,045 -80.0% 16.00 US$480,720
2019-03-05 2019-03-04
S Sale
5,000 -31.4%
68.00
US$340,000 		5,000 -31.4% 68.00 US$340,000
2019-03-05 2019-03-01
S Sale
5,000 -31.4%
66.01
US$330,050 		5,000 -31.4% 66.01 US$330,050
2018-07-27 2018-07-25
PlS Planned sale
2,050 -100.0%
84.58
US$173,389 		2,050 -100.0% 84.58 US$173,389
2018-06-26 2018-06-22
PlS Planned sale
2,050 -100.0%
97.58
US$200,039 		2,050 -100.0% 97.58 US$200,039
2018-05-29 2018-05-23
PlS Planned sale
2,050 -100.0%
85.76
US$175,808 		2,050 -100.0% 85.76 US$175,808
2018-04-25 2018-04-23
PlS Planned sale
2,050 -100.0%
85.95
US$176,198 		2,050 -100.0% 85.95 US$176,198
2018-03-26 2018-03-22
PlS Planned sale
2,050 -100.0%
84.65
US$173,532 		2,050 -100.0% 84.65 US$173,532
2018-02-26 2018-02-22
PlS Planned sale
2,050 -100.0%
78.63
US$161,192 		2,050 -100.0% 78.63 US$161,192
2018-01-25 2018-01-23
PlS Planned sale
25,000 -100.0%
74.83
US$1,870,750 		25,000 -100.0% 74.83 US$1,870,750